Development of basal-Like HaCaT keratinocytes containing the genome of human papillomavirus (HPV) type 11 for screening of anti-HPV effects

Journal of Biomolecular Screening

Volumn 19, Issue 8, 2014, Pages 1154-1163

  Wang, Yongfang ^a   Li, Xinyu ^a   Song, Shasha ^a   Wu, Jianbo ^a  

^a PEKING UNION MEDICAL COLLEGE   (China)

Author keywords

Condylomata acuminata; drug screening; HaCaT keratinocytes; human papillomavirus

Indexed keywords

13 HEXYL BERBERINE HYDROCHLORIDE; 13 HEXYL PALMATINE HYDROCHLORIDE; ANTIVIRUS AGENT; LIQUID NITROGEN; RECOMBINANT ALPHA1B INTERFERON; RECOMBINANT INTERFERON; UNCLASSIFIED DRUG; VIRUS DNA; 13-HEXYLBERBERINE; 13-HEXYLPALMATINE; BERBERINE; BERBERINE DERIVATIVE; DNA BINDING PROTEIN; E1 PROTEIN, HUMAN PAPILLOMAVIRUS TYPE 11; ONCOGENE PROTEIN E4, TYPE 11, HUMAN PAPILLOMAVIRUS; ONCOPROTEIN; VIRAL PROTEIN;

AGAR GEL ELECTROPHORESIS; ANTIVIRAL ACTIVITY; ARTICLE; CELL POPULATION; CELL PROLIFERATION; CELL SURVIVAL; COMPARATIVE STUDY; CONDYLOMA ACUMINATUM; CONTROLLED STUDY; DNA REPLICATION; DRUG SCREENING; GENE EXPRESSION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN PAPILLOMAVIRUS TYPE 11; HUMAN PAPILLOMAVIRUS TYPE 2; KERATINOCYTE; MTT ASSAY; NONHUMAN; PRIORITY JOURNAL; VIRUS GENOME; VIRUS REPLICATION; WART VIRUS; ANALOGS AND DERIVATIVES; CELL LINE; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; PLASMID; POLYMERASE CHAIN REACTION; PRECLINICAL STUDY; PROCEDURES; VIROLOGY;

ANTIVIRAL AGENTS; BERBERINE; BERBERINE ALKALOIDS; CELL LINE; CELL PROLIFERATION; DNA REPLICATION; DNA-BINDING PROTEINS; DRUG EVALUATION, PRECLINICAL; GENE EXPRESSION REGULATION, VIRAL; HUMAN PAPILLOMAVIRUS 11; HUMANS; KERATINOCYTES; ONCOGENE PROTEINS, VIRAL; PLASMIDS; POLYMERASE CHAIN REACTION; VIRAL PROTEINS;

EID: 84905589146     PISSN: 10870571     EISSN: 1552454X     Source Type: Journal    
DOI: 10.1177/1087057114536987     Document Type: Article

References (31)

1. Klymenko T., Graham S. V.. Human Papillomavirus Gene Expression Is Controlled by Host Cell Splicing Factors. Biochem. Soc. Trans. 2012 ; 40: 773-777
2. Stockfleth E., Meyer T.. The Use of Sinecatechins (Polyphenon E) Ointment for Treatment of External Genital Warts. Expert. Opin. Biol. Ther. 2012 ; 12: 783-793
3. Patel H., Wagner M., Singhal P., et al. Systematic Review of the Incidence and Prevalence of Genital Warts. BMC Infect. Dis. 2013 ; 13: 39
4. Stanley M. A.. Genital Human Papillomavirus Infections: Current and Prospective Therapies. J. Gen. Virol. 2012 ; 93: 681-691
5. Brown D. R., Bryan J. T., Pratt L., et al. Human Papillomavirus Type 11 E1̂E4 and L1 Proteins Colocalize in the Mouse Xenograft System at Multiple Time Points. Virology. 1995 ; 214: 259-263
6. Bryan J. T., Jansen K. U., Lowe R. S., et al. Human Papillomavirus Type 11 Neutralization in the Athymic Mouse Xenograft System: Correlation with Virus-Like Particle IgG Concentration. J. Med. Virol. 1997 ; 53: 185-188
7. Parkinson T., Howett M. K., Welsh P. A., et al. An Inhibitor of the Epidermal Growth Factor Receptor Function Does Not Affect the Ability of Human Papillomavirus 11 to Form Warts in the Xenografted Immunodeficient Mouse Model. Antiviral Res. 2007 ; 74: 43-50
8. Doorbar J., Quint W., Banks L., et al. The Biology and Life-Cycle of Human Papillomaviruses. Vaccine. 2012 ; 30: F55 - F70
9. Clark P. R., Roberts M. L., Cowsert L. M.. A Novel Drug Screening Assay for Papillomavirus-Specific Antiviral Activity. Antiviral Res. 1998 ; 37: 97-106
10. Thomas J. T., Oh S. T., Terhune S. S., et al. Cellular Changes Induced by Low-Risk Human Papillomavirus Type 11 in Keratinocytes That Stably Maintain Viral Episomes. J. Virol. 2001 ; 75: 7564-7571
11. Fang L., Meyers C., Budgeon L. R., et al. Induction of Productive Human Papillomavirus Type 11 Life Cycle in Epithelial Cells Grown in Organotypic Raft Cultures. Virology. 2006 ; 347: 28-35
12. Kaczkowski B., Rossing M., Andersen D. K., et al. Integrative Analyses Reveal Novel Strategies in HPV11,-16 and -45 Early Infection. Sci. Rep. 2012 ; 2: 515
13. Deyrieux A. F., Wilson V. G.. In Vitro Culture Conditions to Study Keratinocyte Differentiation Using the HaCaT Cell Line. Cytotechnology. 2007 ; 54: 77-83
14. Wang Y. F., Li X. Y., Song S. S., et al. Establishing of Three-Dimensional Culture Model by HaCaT Keratinocytes Carrying HPV11 Genome and Expression of HPV11 Major Capsid Protein L1 in the Model. Chin. J. AIDS STD. 2010 ; 2: 105-108
15. Wu J. B., Li X. Y., Lin L., et al. In Vitro Antiviral Activity of a Berberine Derivant HB-13 against Herpes Simplex Virus. Chin. J. Dermatol. 2007 ; 40: 671-673
16. Boukamp P., Petrussevska R. T., Breitkreutz D., et al. Normal Keratinization in a Spontaneously Immortalized Aneuploid Human Keratinocyte Cell Line. J. Cell. Biol. 1988 ; 106: 761-771
17. Griffin L. M., Cicchini L., Pyeon D.. Human Papillomavirus Infection Is Inhibited by Host Autophagy in Primary Human Keratinocytes. Virology. 2013 ; 437: 12-19
18. Wang H. K., Duffy A. A., Broker T. R., et al. Robust Production and Passaging of Infectious HPV in Squamous Epithelium of Primary Human Keratinocytes. Genes Dev. 2009 ; 23: 181-194
19. Rogers A. J., Loggen M., Lee K., et al. Varying Efficiency of Long-Term Replication of Papillomaviruses. Saccharomyces cerevisiae. Virology. 2008 ; 381 (1). 6-10
20. Kadaja M., Silla T., Ustav E., et al. Papillomavirus DNA Replication: From Initiation to Genomic Instability. Virology. 2009 ; 384: 360-368
21. Pittayakhajonwut D., Angeletti P. C.. Analysis of Cis-Elements That Facilitate Extrachromosomal Persistence of Human Papillomavirus Genomes. Virology. 2008 ; 374: 304-314
22. McIntosh P. B., Laskey P., Sullivan K., et al. E1̂E4-Mediated Keratin Phosphorylation and Ubiquitylation: A Mechanism for Keratin Depletion in HPV16-Infected Epithelium. J. Cell Sci. 2010 ; 123: 2810-2822
23. Imanshahidi M., Hosseinzadeh H.. Pharmacological and Therapeutic Effects of Berberis vulgaris and Its Active Constituent, Berberine. Phytother. Res. 2008 ; 22: 999-1012
24. Zha W., Liang G., Xiao J., et al. Berberine Inhibits HIV Protease Inhibitor-Induced Inflammatory Response by Modulating ER Stress Signaling Pathways in Murine Macrophages. PLOS ONE. 2010 ; 5: e9069
25. Cecil C. E., Davis J. M., Cech N. B., et al. Inhibition of H1N1 Influenza A Virus Growth and Induction of Inflammatory Mediators by the Isoquinoline Alkaloid Berberine and Extracts of Goldenseal (Hydrastis canadensis). Int. Immunopharmacol. 2011 ; 11: 1706-1714
26. Mahata S., Bharti A. C., Shukla S., et al. Berberine Modulates AP-1 Activity to Suppress HPV Transcription and Downstream Signaling to Induce Growth Arrest and Apoptosis in Cervical Cancer Cells. Mol. Cancer. 2011 ; 10: 39
27. Yang L. M., Wang R. R., Li J. J., et al. Anti-HIV Activities in Vitro of Four Berberine Compounds. Chin. J. Nat. Med. 2007 ; 5: 225-228
28. Johnson J. A., Gangemi J. D.. Alpha Interferon Augments Cidofovir's Antiviral and Antiproliferative Activities. Antimicrob. Agents Chemother. 2003 ; 47: 2022-2026
29. Gerein V., Rastorguev E., Gerein J., et al. Use of Interferon-Alpha in Recurrent Respiratory Papillomatosis: 20-Year Follow-Up. Ann. Otol. Rhinol. Laryngol. 2005 ; 114: 463-471
30. Agarwal C., Hembree J. R., Rorke E. A., et al. Interferon and Retinoic Acid Suppress the Growth of Human Papillomavirus Type 16 Immortalized Cervical Epithelial Cells, but Only Interferon Suppresses the Level of the Human Papillomavirus Transforming Oncogenes. Cancer Res. 1994 ; 54: 2108-2112
31. Johnson J. A., Hochkeppel H. K., Gangemi J. D.. IFN-Tau Exhibits Potent Suppression of Human Papillomavirus E6/E7 Oncoprotein Expression. J. Interferon Cytokine Res. 1999 ; 19: 1107-1116